Pharmacologic control of smooth muscle cells in allografts.
Foegh
M L
ML
Department of Surgery, Georgetown University Medical Center, Washington, DC, USA. mfoegh@aol.com
Ramwell
P W
PW
D000818:Animals; D001120:Arginine / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000276:immunology / Q000473:pathology / Q000517:prevention & control*; D016207:Cytokines / Q000502:physiology; D004958:Estradiol / Q000494:pharmacology* / Q000502:physiology / Q000627:therapeutic use; D005260:Female; D006133:Growth Substances / Q000502:physiology; D016027:Heart Transplantation / Q000009:adverse effects* / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology* / Q000502:physiology / Q000627:therapeutic use; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000276:immunology / Q000473:pathology*; D009569:Nitric Oxide / Q000502:physiology; D009842:Oligopeptides / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D010456:Peptides, Cyclic; D011453:Prostaglandins / Q000502:physiology; D013004:Somatostatin / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D014184:Transplantation, Homologous
D016207:Cytokines; D006133:Growth Substances; D007166:Immunosuppressive Agents; D009842:Oligopeptides; D010456:Peptides, Cyclic; D011453:Prostaglandins; C060347:lanreotide; D009569:Nitric Oxide; D004958:Estradiol; D013004:Somatostatin; D007334:Insulin-Like Growth Factor I; D001120:Arginine